ALLAKOS INC's ticker is ALLK and the CUSIP is 01671P100. A total of 167 filers reported holding ALLAKOS INC in Q1 2021. The put-call ratio across all filers is 0.62 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $163,070 | +100.7% | 71,837 | +285.4% | 0.00% | – |
| Q2 2023 | $81,262 | -26.8% | 18,638 | -25.3% | 0.00% | – |
| Q1 2023 | $111,045 | +16.9% | 24,954 | -17.6% | 0.00% | – |
| Q2 2022 | $95,000 | -66.9% | 30,266 | -40.0% | 0.00% | -100.0% |
| Q1 2022 | $287,000 | -15.3% | 50,429 | +45.8% | 0.00% | 0.0% |
| Q4 2021 | $339,000 | +3.0% | 34,579 | +1013.7% | 0.00% | 0.0% |
| Q3 2021 | $329,000 | -65.9% | 3,105 | -63.1% | 0.00% | -50.0% |
| Q1 2021 | $965,000 | +262.8% | 8,408 | +342.3% | 0.00% | – |
| Q4 2020 | $266,000 | -70.3% | 1,901 | -82.7% | 0.00% | -100.0% |
| Q3 2020 | $895,000 | +8.6% | 10,983 | -4.2% | 0.00% | +100.0% |
| Q2 2020 | $824,000 | +42.8% | 11,467 | -11.6% | 0.00% | 0.0% |
| Q1 2020 | $577,000 | -57.3% | 12,977 | -8.3% | 0.00% | -50.0% |
| Q4 2019 | $1,350,000 | – | 14,159 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RiverVest Venture Management LLC | 4,887,932 | $29,914,000 | 34.73% |
| Logos Global Management LP | 5,936,666 | $36,332,000 | 4.47% |
| TCG Crossover Management, LLC | 1,643,500 | $10,058,000 | 3.02% |
| Vivo Capital, LLC | 4,120,134 | $25,215,000 | 2.78% |
| Ally Bridge Group (NY) LLC | 598,172 | $3,661,000 | 2.42% |
| Frazier Life Sciences Management, L.P. | 4,792,000 | $29,327,000 | 2.26% |
| NEA Management Company, LLC | 6,148,704 | $33,867,000 | 1.69% |
| COMMODORE CAPITAL LP | 1,643,500 | $10,058,000 | 1.62% |
| BVF INC/IL | 5,006,921 | $30,642,000 | 1.27% |
| Deep Track Capital, LP | 4,518,575 | $27,654,000 | 1.27% |